Olink Holding AB (Olink Holding AB) Gross-Profit-to-Asset % : 33.71% (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Olink Holding AB Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Olink Holding AB's annualized Gross Profit for the quarter that ended in Dec. 2023 was $194.7 Mil. Olink Holding AB's average Total Assets over the quarter that ended in Dec. 2023 was $577.5 Mil. Therefore, Olink Holding AB's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2023 was 33.71%.

Olink Holding AB Gross-Profit-to-Asset % Historical Data

The historical data trend for Olink Holding AB's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Olink Holding AB Gross-Profit-to-Asset % Chart

Olink Holding AB Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Gross-Profit-to-Asset %

8.27

9.48

12.06

18.60

21.23

Olink Holding AB Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Gross-Profit-to-Asset %	Get a 7-Day Free Trial												37.73	13.60	12.69	22.81	33.71

Competitive Comparison of Olink Holding AB's Gross-Profit-to-Asset %

For the Diagnostics & Research subindustry, Olink Holding AB's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Olink Holding AB's Gross-Profit-to-Asset % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Olink Holding AB's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Olink Holding AB's Gross-Profit-to-Asset % falls into.

Olink Holding AB Gross-Profit-to-Asset % Calculation

Olink Holding AB's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2023 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (A: Dec. 2023 )	/	( (Total Assets (A: Dec. 2022 )	+	Total Assets (A: Dec. 2023 ))	/ count )
	=	114.461	/	( (476.29	+	602.252)	/ 2 )
	=	114.461	/	539.271
	=	21.23 %

Olink Holding AB's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2023 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (Q: Dec. 2023 )	/	( (Total Assets (Q: Sep. 2023 )	+	Total Assets (Q: Dec. 2023 ))	/ count )
	=	194.676	/	( (552.825	+	602.252)	/ 2 )
	=	194.676	/	577.5385
	=	33.71 %

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Dec. 2023) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.

Olink Holding AB Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Olink Holding AB's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.

Olink Holding AB (Olink Holding AB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Olink Holding AB (NAS:OLK) » Definitions » Gross-Profit-to-Asset %

Comparable Companies

Traded in Other Exchanges

6XA:Germany

Address

Uppsala Science Park, Uppsala, SWE, SE-75183

Website

https://www.olink.com

Olink Holding AB has a proprietary and patented Proximity Extension Assay technology, which enables researchers to use one platform for discovery to clinical trials to diagnostic applications utilizing the established infrastructure of labs and installed instrumentation. It has two segments including Kit and Services. It derives revenues from Sweden, the Americas, China, EMEA (Excluding Sweden) Japan, and other regions.